Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe
Argenics: Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled… · Jul 29–Aug 1, 2026
NewThe campaign promotes the Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe, emphasizing the convenience and control of self-injection for a flexible treatment routine.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
Shows
Where the campaign appearedRepresentative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
With the Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe, self-injection is in your hands. It's your treatment routine. Use at the time and same day each week. Take the pre-filled syringe with you on vacation or have it handy for cozy staycations. For more information, visit livevividly.com. That's L-I-V-E-V-Y-V-I-D-L-Y.com. Brought to you by Argenics.
More campaigns from Argenics
Other published campaigns from this sponsor
The campaign promoted the Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and Hyaluronidase QVFC, by emphasizing the convenience and personal control of self-injecting treatment on one's own terms.
Argenics partners with Ruby Studio to produce "Untold Stories, Life with a Severe Autoimmune Condition," a podcast that explores the experiences of individuals living with various rare autoimmune conditions and fosters a sense of community.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.